HKAM
PFE icon

Horizon Kinetics Asset Management’s Pfizer PFE Stock Holding History

Horizon Kinetics Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Buy
69,662
+712
+1% +$18.6K 0.02% 126
2026
Q1 		$1.94M Buy
68,950
+1,279
+2% +$34.1K 0.02% 123
2025
Q4 		$1.69M Sell
67,671
-3,155
-4% -$79.6K 0.02% 125
2025
Q3 		$1.8M Sell
70,826
-32,357
-31% -$799K 0.02% 125
2025
Q2 		$2.5M Buy
103,183
+3,157
+3% +$73.6K 0.03% 107
2025
Q1 		$2.53M Sell
100,026
-677
-0.7% -$17.7K 0.03% 106
2024
Q4 		$2.67M Buy
100,703
+6,888
+7% +$187K 0.03% 108
2024
Q3 		$2.72M Buy
93,815
+36,370
+63% +$1.06M 0.04% 103
2024
Q2 		$1.61M Buy
57,445
+300
+0.5% +$8.26K 0.03% 121
2024
Q1 		$1.59M Buy
57,145
+6,979
+14% +$194K 0.03% 119
2023
Q4 		$1.44M Sell
50,166
-255
-0.5% -$7.71K 0.03% 122
2023
Q3 		$1.67M Buy
50,421
+1,850
+4% +$65.4K 0.03% 109
2023
Q2 		$1.78M Buy
48,571
+209
+0.4% +$8.13K 0.04% 106
2023
Q1 		$1.97M Sell
48,362
-2,550
-5% -$110K 0.04% 99
2022
Q4 		$2.61M Hold
50,912
– – 0.04% 84
2022
Q3 		$2.23M Sell
50,912
-654
-1% -$31.8K 0.04% 89
2022
Q2 		$2.7M Sell
51,566
-1,940
-4% -$98.9K 0.06% 84
2022
Q1 		$2.77M Hold
53,506
– – 0.06% 97
2021
Q4 		$3.16M Buy
53,506
+189
+0.4% +$9.36K 0.07% 89
2021
Q3 		$2.29M Sell
53,317
-1,100
-2% -$48.7K 0.05% 108
2021
Q2 		$2.13M Sell
54,417
-3,268
-6% -$127K 0.04% 120
2021
Q1 		$2.09M Buy
57,685
+2,253
+4% +$80K 0.05% 118
2020
Q4 		$2.04M Sell
55,432
-11,030
-17% -$405K 0.07% 111
2020
Q3 		$2.31M Buy
66,462
+1,660
+3% +$58.2K 0.09% 100
2020
Q2 		$2.01M Sell
64,802
-3,945
-6% -$134K 0.07% 103
2020
Q1 		$2.13M Buy
68,747
+1,257
+2% +$42.8K 0.09% 84
2019
Q4 		$2.51M Buy
67,490
+2,064
+3% +$73.5K 0.07% 88
2019
Q3 		$2.23M Sell
65,426
-3,475
-5% -$126K 0.07% 102
2019
Q2 		$2.83M Sell
68,901
-1,199
-2% -$47.6K 0.08% 93
2019
Q1 		$2.83M Buy
+70,100
New +$2.81M 0.08% 94

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Horizon Kinetics Asset Management's PFE Position: Q2 2026 in Review

Horizon Kinetics Asset Management increased its Pfizer (PFE) stake by 1% in Q2 2026, buying an estimated $18.6K and bringing the position to 69,662 shares worth $1.68M. The position accounts for 0.02% of the portfolio, ranked #126.

Horizon Kinetics Asset Management first reported a position in PFE in Q1 2019 and has held it in 30 quarters since. The position peaked at $3.16M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Horizon Kinetics Asset Management held 69,662 shares of Pfizer worth $1.68M as of Q2 2026.
  • Horizon Kinetics Asset Management bought 712 Pfizer shares in Q2 2026, an estimated $18.6K.
  • Pfizer made up 0.02% of Horizon Kinetics Asset Management's portfolio in Q2 2026, its #126 holding.
  • Horizon Kinetics Asset Management first reported a position in Pfizer in Q1 2019 and has held it in 30 quarters since.
  • Horizon Kinetics Asset Management's Pfizer position peaked at $3.16M in Q4 2021.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Horizon Kinetics Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.